K. Brakora

GBP1 overexpression is associated with a paclitaxel resistance phenotype

Z. Duan, R. Foster, M. Seiden, 2005, Cancer Chemotherapy and Pharmacology.

Inhibition of ABCB 1 ( MDR 1 ) and ABCB 4 ( MDR 3 ) expression by small interfering RNA and reversal of paclitaxel resistance in human ovarian cancer cells

Z. Duan, M. Seiden, K. Brakora, 2004 .

MM-TRAG (MGC4175), a novel intracellular mitochondrial protein, is associated with the taxol- and doxorubicin-resistant phenotype in human cancer cell lines.

Z. Duan, M. Seiden, K. Brakora, 2004, Gene.

Utility of osteopontin as a biomarker in recurrent epithelial ovarian cancer.

A. Harris, M. Seiden, R. Yusuf, 2004, Gynecologic oncology.

FGFR‐associated craniosynostosis syndromes and gastrointestinal defects

R. Marcucio, S. Bowdin, C. Forrest, 2016, American journal of medical genetics. Part A.

Evolution of ruminant headgear: a review

E. Davis, K. Brakora, Andrew H Lee, 2011, Proceedings of the Royal Society B: Biological Sciences.

Inhibition of ABCB1 (MDR1) and ABCB4 (MDR3) expression by small interfering RNA and reversal of paclitaxel resistance in human ovarian cancer cells.

Z. Duan, M. Seiden, K. Brakora, 2004, Molecular cancer therapeutics.

BMS-247550 Bristol-Myers Squibb/GBF.

M. Seiden, N. Lin, K. Brakora, 2003, Current opinion in investigational drugs.

Ecology, Evolution and Behaviour of Wild Cattle: Evolution, development and functional role of horns in cattle

E. Davis, K. Stilson, K. Brakora, 2014 .